Windlas Biotech Limited has informed the Exchange about completion of despatch of Annual Report for the fianancial year 2024-25
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech Limited has informed the stock exchanges that it has completed the despatch of the Notice of its 24th Annual General Meeting along with the Annual Report for the financial year 2024-25 to its members. Newspaper advertisements confirming this despatch were published on July 6, 2025 in the Financial Express (all editions) and Rastriya Sahara (Dehradun edition in Hindi), as required under SEBI Listing Regulations and the Companies Act, 2013. The company has also sent a separate letter containing the web link of its website (www.windlas.com) to those shareholders whose email addresses are not registered, in compliance with Regulation 36(1)(b) of SEBI LODR. The filing was made under Regulation 30 of the SEBI Listing Regulations by Ananta Narayan Panda, Company Secretary & Compliance Officer.
This is a routine regulatory disclosure confirming that shareholders have been formally notified about the 24th AGM and have received the Annual Report. It does not indicate any change in business or financial performance and is unlikely to have any direct impact on the stock price.